Trial · NCT05439902
Registered outcomes30
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 30
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Urinary symptoms between groups | Start of first intervention phase (Day 0) | Measured using the International Prostate Symptom Scale (IPSS), scoring ranging from 0-35 |
| Primary | Urinary symptoms between groups | End of first intervention phase (Day 30) | Measured using the International Prostate Symptom Scale (IPSS), scoring ranging from 0-35 |
| Primary | Urinary symptoms between groups | Start of first intervention phase (Day 60) | Measured using the International Prostate Symptom Scale (IPSS), scoring ranging from 0-35 |
| Primary | Urinary symptoms between groups | End of first intervention phase (Day 90) | Measured using the International Prostate Symptom Scale (IPSS), scoring ranging from 0-35 |
| Secondary | Urinary symptoms between groups | Start of first intervention phase (Day 0) | Measured using the Urinary Symptom Profile (USP) questionnaire: score ranging from 0-39 |
| Secondary | Urinary symptoms between groups | End of first intervention phase (Day 30) | Measured using the Urinary Symptom Profile (USP) questionnaire: score ranging from 0-39 |
| Secondary | Urinary symptoms between groups | Start of first intervention phase (Day 60) | Measured using the Urinary Symptom Profile (USP) questionnaire: score ranging from 0-39 |
| Secondary | Urinary symptoms between groups | End of first intervention phase (Day 90) | Measured using the Urinary Symptom Profile (USP) questionnaire: score ranging from 0-39 |
| Secondary | Post-mictional residue between groups | Start of first intervention phase (Day 0) | ml, measured with BladderScan |
| Secondary | Post-mictional residue between groups | End of first intervention phase (Day 30) | ml, measured with BladderScan |
| Secondary | Post-mictional residue between groups | Start of first intervention phase (Day 60) | ml, measured with BladderScan |
| Secondary | Post-mictional residue between groups | End of first intervention phase (Day 90) | ml, measured with BladderScan |
| Secondary | Maximum urine flow rate between groups | Start of first intervention phase (Day 0) | ml/s |
| Secondary | Maximum urine flow rate between groups | End of first intervention phase (Day 30) | ml/s |
| Secondary | Maximum urine flow rate between groups | Start of first intervention phase (Day 60) | ml/s |
| Secondary | Maximum urine flow rate between groups | End of first intervention phase (Day 90) | ml/s |
| Secondary | Quality of life linked to urinary dysfunction between groups | Start of first intervention phase (Day 0) | Qualiveen-30 questionnaire; score 0-4 |
| Secondary | Quality of life linked to urinary dysfunction between groups | End of first intervention phase (Day 30) | Qualiveen-30 questionnaire; score 0-4 |
| Secondary | Quality of life linked to urinary dysfunction between groups | Start of first intervention phase (Day 60) | Qualiveen-30 questionnaire; score 0-4 |
| Secondary | Quality of life linked to urinary dysfunction between groups | End of first intervention phase (Day 90) | Qualiveen-30 questionnaire; score 0-4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05439902/registered